Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment (May, 10.1245/s10434-021-10146-3, 2021)

Pascal K. C. Jonker, John Turchini, Schelto Kruijff, Jia Feng Lin, Anthony J. Gill, Thomas Eade, Ahmad Aniss, Roderick Clifton-Bligh, Diana Learoyd, Bruce Robinson, Venessa Tsang, Anthony Glover, Stanley Sidhu, Mark Sywak^*

^*Corresponding author for this work

Guided Treatment in Optimal Selected Cancer Patients (GUTS)

Research output: Contribution to journal › Article › Academic › peer-review

5 Downloads (Pure)

1 Article

1 results

2021

Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment
Jonker, P. K. C., Turchini, J., Kruijff, S., Lin, J. F., Gill, A. J., Eade, T., Ahniss, A., Clifton-Bligh, R., Learoyd, D., Robinson, B., Tsang, V., Glover, A., Sidhu, S. & Sywak, M., Nov-2021, In: Annals of Surgical Oncology. 28, 12, p. 7520-7530 11 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

3 Citations (Scopus)

40 Downloads (Pure)

Research output

Search results

Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment